CSIMarket
 
Endonovo Therapeutics Inc   (ENDV)
Other Ticker:  
 

Endonovo Therapeutics Inc

Business Description


Endonovo Therapeutics Inc, founded in 2011, is a bioelectronic medicine company that develops and commercializes innovative therapies for both acute and chronic inflammatory conditions. The company is headquartered in Woodland Hills, California.

Endonovo Therapeutics is focused on the development and commercialization of non-invasive bioelectronic therapies, which utilize safe electromagnetic fields to stimulate the body*s natural healing processes. The company*s proprietary technologies aim to address various medical conditions including pain management, tissue regeneration, and inflammation.

The flagship product of Endonovo Therapeutics is called SofPulse, which is a non-invasive device designed to stimulate the body*s natural healing response by reducing inflammation and promoting tissue regeneration. SofPulse is based on pulsed electromagnetic field (PEMF) technology and is used in the post-operative care setting to accelerate wound healing and reduce pain.

SofPulse delivers low-frequency electromagnetic fields to the body, which have been shown to enhance the body*s cellular communication system and promote healing at the cellular level. The device is currently being used in hospitals and surgical centers across the United States, showing positive results in reducing pain, edema, and opioid use in post-operative patients.

In addition to SofPulse, Endonovo Therapeutics is also developing other bioelectronic therapies for various medical conditions. These include Cytotronics, a platform technology designed to treat a range of diseases and disorders by modulating the body*s electrical signaling system, and Immunotronics, which aims to stimulate the immune system and enhance its response to infections and diseases.

The company*s development pipeline also includes Exosomes, which are naturally occurring extracellular vesicles that play a crucial role in cell-to-cell communication and have shown potential in regenerative medicine. Endonovo Therapeutics is exploring the therapeutic applications of exosomes in wound healing, tissue repair, and other medical conditions.

Endonovo Therapeutics operates in collaboration with leading academic institutions, research organizations, and medical centers to advance its technologies. The company*s research and development efforts focus on conducting pre-clinical and clinical trials to demonstrate the safety and efficacy of its bioelectronic therapies.

Overall, Endonovo Therapeutics Inc is a bioelectronic medicine company that is dedicated to developing and commercializing innovative therapies for inflammatory conditions. The company*s flagship product, SofPulse, has demonstrated positive results in accelerating wound healing and reducing pain in post-operative patients. With a robust pipeline of bioelectronic therapies, Endonovo Therapeutics is poised to make a significant impact in the field of regenerative medicine.



View Company Supplier View Company Competition View Company Customers


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com